Hyperlipemia
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AstraZenecaRosuvastatin 10mg/d group
Suzhou Ribo Life Science CompanyRBD7022
Clinical Trials (2)
Total enrollment: 300 patients across 2 trials
Effect of Rosuvastatin Therapy on HDL2 Level
Start: Nov 2015Est. completion: Jun 2017300 patients
Phase 4Unknown
A Single and Multiple Ascending Doses Study to Evaluate the Safety, Tolerability and Pharmacokinetics of RBD7022
Start: May 2023Est. completion: Mar 2025
Phase 1Completed
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space